TrialJournal of palliative medicine2015

Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension.

Janet Bull et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.